A 59-year-old woman with obesity and metabolic syndrome has mildly elevated liver enzymes and ultrasound evidence of hepatic steatosis. Viral hepatitis and alcohol misuse have been excluded. She is diagnosed with non-alcoholic fatty liver disease. According to Canadian recommendations, what is the cornerstone of management?